Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Endosomal TLRs play an important role in innate immune response as well as in autoimmune processes. In the therapy of systemic lupus erythematosus, antimalarial drugs chloroquine, hydroxychloroquine, and quinacrine have been used for a long time. Their suppression of endosomal TLR activation has been attributed to the inhibition of endosomal acidification, which is a prerequisite for the activation of these receptors. We discovered that chloroquine inhibits only activation of endosomal TLRs by nucleic acids, whereas it augments activation of TLR8 by a small synthetic compound, R848. We detected direct binding of antimalarials to nucleic acids by spectroscopic experiments and determined their cellular colocalization. Further analysis revealed that other nucleic acid-binding compounds, such as propidium iodide, also inhibited activation of endosomal TLRs and colocalized with nucleic acids to endosomes. We found that imidazoquinolines, which are TLR7/8 agonists, inhibit TLR9 and TLR3 even in the absence of TLR7 or TLR8, and their mechanism of inhibition is similar to the antimalarials. In contrast to bafilomycin, none of the tested antimalarials and imidazoquinolines inhibited endosomal proteolysis or increased the endosomal pH, confirming that inhibition of pH acidification is not the underlying cause of inhibition. We conclude that the direct binding of inhibitors to nucleic acids mask their TLR-binding epitope and may explain the efficiency of those compounds in the treatment…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In phagocytic cells, the deacidification of endosomes using pharmacological inhibitors like chloroquine has been shown to reduce endosomal toll-like receptor (TLR) response (de Bouteiller et al., 2005; Fox, 2019; Kuznik et al., 2011; Wozniacka et al., 2006; Yang et al., 2016)”
From NHE6 depletion corrects ApoE4-mediated synaptic impairments and reduces amyloid plaque load (2021) · cites this paper as Kuznik et al., 2011
In the citing paper
“Hydroxychloroquine (HCQ) is an approved anti-malaria drug, and accumulation of hydroxychloroquine inhibits the binding ability of TLR9 to DNA and subsequent immune activation (77).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [77]
Citations
Cites
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,522
ACIDIFICATION OF THE ENDOCYTIC AND EXOCYTIC PATHWAYS
Mellman, I., Fuchs, R., & Helenius, A. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.003311 · Cited by 2,032
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., & Tashiro, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47429-2 · Cited by 1,328
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116
Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., & Coffman, R. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050914 · Cited by 928
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8
Gorden, K. B., Gorski, K. S., Gibson, S. J., Kedl, R. M., Kieper, W. C., Qiu, X., Tomai, M. A., Alkan, S. S., & Vasilakos, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1259 · Cited by 683
Häcker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Lipford, G. B., & Wagner, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6230 · Cited by 653
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor
Ewald, S. E., Lee, B. L., Lau, L., Wickliffe, K. E., Shi, G.-P., Chapman, H. A., & Barton, G. M. (2008) · Nature · doi:10.1038/nature07405 · Cited by 617
Research works printed but not linked: 2
- Ahmad-Nejad, 2002, Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments, Eur. J. Immunol., 32, 1958, 10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · DOI · Paper page
- Peacocke, 1973, Acridines, 723
Cited by
Items 301–400 of 627
Long, Z., Wang, X., Xiao, W., Yu, M., Qu, F., Zhang, B., & Zeng, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1432625 · Cited by 28
Said, A., Bock, S., Müller, G., & Weindl, G. (2014) · Immunology · doi:10.1111/imm.12363 · Cited by 25
Upcoming therapeutic targets in cutaneous lupus erythematous
Klaeschen, A. S., & Wenzel, J. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1145543 · Cited by 22
Discovery of Novel Small Molecule Dual Inhibitors Targeting Toll-Like Receptors 7 and 8
Padilla‐Salinas, R., Anderson, R. L., Sakaniwa, K., Zhang, S., Nordeen, P., Lu, C., Shimizu, T., & Yin, H. H. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01201 · Cited by 21
Canti, V., Scarrone, M., LORENZO, R. D., Ramirez, G. A., Erra, R., Bordoli, S., Cella, S., Schmit, E., Rosa, S., Castiglioni, M. T., et al. (2021) · Immunological Medicine · doi:10.1080/25785826.2020.1868652 · Cited by 22
Post, S., Rueschpler, L., & Schloer, S. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108051 · Cited by 21
Discovery of Novel Small Molecule Dual Inhibitor Targeting Toll-Like Receptors 7 and 9
Haseeb, M., Choi, Y. S., Patra, M. C., Jeong, U., Lee, W. H., Qayyum, N., Choi, H., Kim, W., & Choi, S. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00578 · Cited by 20
Modulating Toll-like Receptor 7 and 9 Responses as Therapy for Allergy and Autoimmunity
Matešić, D., Lenert, A., & Lenert, P. S. (2011) · Current Allergy and Asthma Reports · doi:10.1007/s11882-011-0233-4 · Cited by 20
Autoantibodies, complement and type I interferon as biomarkers for personalized medicine in SLE
Biesen, R., Rose, T., Hoyer, B. F., Alexander, T., & Hiepe, F. (2016) · Lupus · doi:10.1177/0961203316640922 · Cited by 20
Compromised mitochondrial quality control triggers lipin1-related rhabdomyolysis
Hamel, Y., Mauvais, F., Madrange, M., Renard, P., Lebreton, C., Nemazanyy, I., Pellé, O., Goudin, N., Tang, X., Rodero, M. P., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100370 · Cited by 20
Vultaggio, A., Nencini, F., Pratesi, S., Petroni, G., Romagnani, S., & Maggi, E. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02876.x · Cited by 21
Gupta, C. L., Akhtar, S., Waye, A., Pandey, N. R., Pathak, N., & Bajpai, P. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.121 · Cited by 20
Lin, Y.-S., Chang, Y., Pu, T.-Y., Chuang, T., & Hsu, L.-C. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01151-9 · Cited by 19
Treatment Update in Systemic Lupus Erythematous
Hoi, A. Y.-B., & Morand, E. F. (2021) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2021.04.012 · Cited by 19
B cell–intrinsic Myd88 regulates disease progression in murine lupus
Tilstra, J. S., Kim, M.-J., Gordon, R. A., Leibler, C., Cosgrove, H. A., Bastacky, S., Nickerson, K. M., & Shlomchik, M. J. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230263 · Cited by 20
Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients
Zentsová, I., Paračková, Z., Kayserová, J., Palová-Jelínková, L., Vrabcová, P., Volfová, N., Šumník, Z., Průhová, Š., Petruželková, L., & Šedivá, A. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.06.005 · Cited by 19
Nucleic Acid Immunity in the Pathogenesis of Cutaneous Lupus Erythematosus
Günther, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01636 · Cited by 20
Biologic Functions of Hydroxychloroquine in Disease: From COVID-19 to Cancer
Niemann, B. R., Puleo, A., Stout, C., Markel, J., & Boone, B. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122551 · Cited by 21
Pan, X., Yue, J., Ding, G., Li, B., Liu, X. B., Zheng, X., Yu, M., Li, J., Jiang, W., Wu, C., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.396432 · Cited by 21
Xi, Y., Finlayson, A., White, O. J., Carroll, M. L., & Upham, J. W. (2015) · Clinical & Translational Immunology · doi:10.1038/cti.2015.27 · Cited by 18
Scott, R., Greenwood, S. L., Hayes, D. J. L., Baker, B., Jones, R. L., & Heazell, A. E. P. (2019) · Reproductive Toxicology · doi:10.1016/j.reprotox.2019.05.056 · Cited by 20
Cho, K. H. T., Wassink, G., Galinsky, R., Xu, B., Mathai, S., Dhillon, S. K., van den Heuij, L. G., Davidson, J. O., Weaver-Mikaere, L., Bennet, L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45872-y · Cited by 18
da Silva, A. E. A., de Abreu, P. M. B., Geraldes, D. C., & Nascimento, L. D. O. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102512 · Cited by 18
Wu, J., Su, W., Powner, M. B., Liu, J., Copland, D. A., Fruttiger, M., Madeddu, P. R., Dick, A. D., & Liu, L. (2016) · Scientific Reports · doi:10.1038/srep31873 · Cited by 18
Chizzolini, C., Guéry, J., Noulet, F., Gruaz, L., Cénac, C., Frasca, L., Spoerl, D., Arlettaz, L., Horisberger, A., Ribi, C., et al. (2024) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2024.100252 · Cited by 17
Hovden, A., Karlsen, M., Jonsson, R., & Appel, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031217 · Cited by 17
Figueroa‐Lozano, S., Valk‐Weeber, R. L., Akkerman, R., Abdulahad, W. H., van Leeuwen, S. S., Dijkhuizen, L., & de Vos, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00790 · Cited by 17
Nucleic acid-sensing toll-like receptors: Important players in Sjögren’s syndrome
Alexopoulou, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.980400 · Cited by 18
Shuai, L., She, J., Diao, R., Zhao, H., Liu, X., Hu, Q., Li, D., Su, D., Ye, X., Guo, Y. P., et al. (2023) · American Journal of Reproductive Immunology · doi:10.1111/aji.13686 · Cited by 17
Molecular cloning and characterization of a novel anti-TLR9 intrabody
Reimer, E., Somplatzki, S., Zegenhagen, D., Hänel, S., Fels, A., Bollhorst, T., Hovest, L., Bauer, S., Kirschning, C. J., & Böldicke, T. W. (2013) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-013-0098-8 · Cited by 17
Pharmacotherapy Pearls in Rheumatology for the Care of Older Adult Patients
Betancourt, B. Y., Biehl, A. J., Katz, J. D., & Subedi, A. (2018) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2018.03.010 · Cited by 19
Choi, M., Xu, J., Lee, S., Yeon, S. H., Park, S. K., Rha, K., & Kim, Y. M. (2020) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2020.12.6.994 · Cited by 17
Firestone, T. M., Oyewole, O. O., Reid, S. P., & Ng, C. L. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00222 · Cited by 17
Assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine using the CiPA concept
Thomet, U., Amuzescu, B. P., Knott, T., Mann, S. A., Mubagwa, K., & Radu, B. M. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174632 · Cited by 18
Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
Infante, M., Padilla, N., Alejandro, R., Caprio, M., Della‐Morte, D., Fabbri, A., & Ricordi, C. (2022) · Medicina · doi:10.3390/medicina58050571 · Cited by 19
de Reus, Y. A., Hagedoorn, P., Sturkenboom, M. G. G., Grasmeijer, F., Bolhuis, M. S., Sibum, I., Kerstjens, H. A. M., Frijlink, H. W., & Akkerman, O. W. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272034 · Cited by 17
Biswas, I., Singh, B., Sharma, M., Agrawala, P. K., & Khan, G. A. (2015) · European Journal of Immunology · doi:10.1002/eji.201545597 · Cited by 18
Bagar, T., & Benčina, M. (2012) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2012.07.007 · Cited by 17
Self-citationJoris, F., Smedt, S. C. D., & Raemdonck, K. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.012 · Cited by 17
Toll-Like Receptor-Dependent Immunomodulatory Activity of Pycnogenol®
Verlaet, A. A. J., van der Bolt, N., Meijer, B., Breynaert, A., Naessens, T., Konstanti, P., Smidt, H., Hermans, N., Savelkoul, H. F. J., & Teodorowicz, M. (2019) · Nutrients · doi:10.3390/nu11020214 · Cited by 17
TLR7 activation in epilepsy of tuberous sclerosis complex
Dombkowski, A. A., Cukovic, D., Bagla, S., Jones, M., Caruso, J. A., Chugani, H. T., & Chugani, D. C. (2019) · Inflammation Research · doi:10.1007/s00011-019-01283-3 · Cited by 18
Chen, L., Chen, H., Dong, S., Huang, W., Chen, L., Wei, Y., Shi, L., Li, J., Zhu, F., Zhu, Z., et al. (2020) · Function · doi:10.1093/function/zqaa012 · Cited by 17
Li, H., Fletcher-Etherington, A., Hunter, L., Keshri, S., Fielding, C. A., Nightingale, K., Ravenhill, B. J., Nobre, L., Potts, M., Antrobus, R., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.02.013 · Cited by 16
Potent adjuvantic activity of a CCR1-agonistic bis-quinoline
Ukani, R., Lewis, T. C., Day, T. P., Wu, W., Malladi, S. S., Warshakoon, H. J., & David, S. A. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.11.014 · Cited by 16
Chloroquine inhibits pro-inflammatory effects of heme on macrophages and in vivo
Silva, R. C. M. C., Tan, L. B., Rodrigues, D. A., Prestes, E. B., Gomes, C. P., Gama, A. M. D. S., de Oliveira, P. L., Paiva, C., Manoury, B., & Bozza, M. T. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.028 · Cited by 17
Pichulik, T., Khatamzas, E., Liu, X., Brain, O., Garcia, M. D., Leslie, A. J., Danis, B., Mayer, A., Baban, D. F., Ragoussis, J., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201444970 · Cited by 17
Imaizumi, T., Hayakari, R., Matsumiya, T., Yoshida, H., Tsuruga, K., Watanabe, S., Kawaguchi, S., & Tanaka, H. (2017) · Modern Rheumatology · doi:10.1080/14397595.2017.1289646 · Cited by 16
Pattern Recognition Receptors in Immune Disorders Affecting the Skin
de Koning, H. D., Simon, A., Zeeuwen, P. L. J. M., & Schalkwijk, J. (2012) · Journal of Innate Immunity · doi:10.1159/000335900 · Cited by 17
Both, T., van de Peppel, J., Zillikens, M. C., Koedam, M., van Leeuwen, J. P. T. M., van Hagen, P. M., van Daele, P. L. A., & van der Eerden, B. C. J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13373 · Cited by 16
Reappraisal of Antimalarials in Interferonopathies: New Perspectives for Old Drugs
Piscianz, E., Cuzzoni, E., Sharma, R., Tesser, A., Sapra, P., & Tommasini, A. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666170911162331 · Cited by 15
Ding, X., Pang, Y., Liu, Q., Zhang, H., Wu, J., Lei, J., & Zhang, T. (2024) · Small · doi:10.1002/smll.202306483 · Cited by 16
Mechanisms Underlying Potential Therapeutic Approaches for COVID-19
Benani, A., & Mkaddem, S. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01841 · Cited by 15
Toll-Like Receptor 3 in Cardiovascular Diseases
Zhuang, C., Chen, R., Zheng, Z., Lu, J., & Hong, C. (2022) · Heart Lung and Circulation · doi:10.1016/j.hlc.2022.02.012 · Cited by 17
Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting
Stergioti, E. M., Manolakou, T., Boumpas, D. T., & Banos, A. (2022) · Biomedicines · doi:10.3390/biomedicines10112820 · Cited by 19
Kobayashi, T., & Toyama‐Sorimachi, N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1243104 · Cited by 15
Banović, F., Robson, D., Линек, М., & Olivry, T. (2017) · Veterinary Dermatology · doi:10.1111/vde.12448 · Cited by 15
Giri, A., Das, A., Sarkar, A. K., & Giri, A. K. (2020) · Genes and Environment · doi:10.1186/s41021-020-00164-0 · Cited by 15
A case series of dermatomyositis following SARS-CoV-2 vaccination
Chan, A. R., Tervaert, J. W. C., Redmond, D., Yacyshyn, E., Ferrara, G., Hwang, P. M., Osman, M., & Gniadecki, R. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1013378 · Cited by 14
Gajić, M., Schröder‐Heurich, B., & Mayer-Pickel, K. I. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1298928 · Cited by 14
In VivoTLR9 Inhibition Attenuates CpG-Induced Myocardial Dysfunction
Boehm, O., Markowski, P., van der Giet, M., Gielen, V., Kokalova, A., Brill, C. B., Hoeft, A., Baumgarten, G., Meyer, R., & Knuefermann, P. (2013) · Mediators of Inflammation · doi:10.1155/2013/217297 · Cited by 14
Genetic susceptibility to hydroxychloroquine retinal toxicity
Mack, H. G., Kowalski, T., Lucattini, A., Symons, R. C. A., Wicks, I., & Hall, A. (2020) · Ophthalmic Genetics · doi:10.1080/13816810.2020.1747093 · Cited by 15
Chloroquine as a promising adjuvant therapy for type 1 Diabetes Mellitus
Júnior, R. F. D. A., de Souza, K. S. C., Galdino, O. A., da Silva-Júnior, A. A., Arrais, R. F., Machado, P. R. L., Farias, K. J. S., & de Rezende, A. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-69001-2 · Cited by 15
Gillard, J., Suffiotti, M., Brázda, P., Venkatasubramanian, P. B., Versteegen, P., de Jonge, M. I., Kelly, D. F., Bibi, S., Pinto, M. V., Simonetti, E. R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46560-w · Cited by 14
Label-free biosensor assay decodes the dynamics of Toll-like receptor signaling
Holze, J., Lauber, F., Soler, S., Kostenis, E., & Weindl, G. (2024) · Nature Communications · doi:10.1038/s41467-024-53770-9 · Cited by 13
Sayyar, R., Makarem, S., & Mirza, B. (2019) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.3562 · Cited by 13
Fetter, T., & Wenzel, J. (2020) · Experimental Dermatology · doi:10.1111/exd.14146 · Cited by 13
Sato, R., Imaizumi, T., Aizawa, T., Watanabe, S., Tsugawa, K., Kawaguchi, S., Seya, K., Matsumiya, T., & Tanaka, H. (2021) · Renal Failure · doi:10.1080/0886022x.2021.1908901 · Cited by 14
Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy
Tanaka, H., Joh, K., & Imaizumi, T. (2017) · Clinical and Experimental Nephrology · doi:10.1007/s10157-017-1381-1 · Cited by 13
Fritscher, J., Amberger, D. C., Dyckhoff-Shen, S., Bewersdorf, J. P., Masouris, I., Völk, S., Hammerschmidt, S., Schmetzer, H. M., Klein, M., Pfister, H., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00550 · Cited by 14
Endosomes serve as signaling platforms for RIG-I ubiquitination and activation
Chen, K., Yang, C.-Y., Shu, S.-G., Lo, Y.-C., Lee, K.-W., Wang, L.-C., Chen, J.-B., Shih, M.-C., Chang, H.-C., Hsiao, Y.-J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq0660 · Cited by 12
Habas, A., Natala, S. R., Bowden-Verhoek, J. K., Stocking, E. M., Price, D. L., Wrasidlo, W., Bonhaus, D. W., & Gill, M. B. (2022) · International Journal of Inflammation · doi:10.1155/2022/2337363 · Cited by 17
Viryasova, G. M., Golenkina, E. A., Galkina, S. I., Gaponova, T. V., Romanova, Y. M., & Sud’ina, G. F. (2016) · Biochimie · doi:10.1016/j.biochi.2016.03.010 · Cited by 12
Assessing the Inhibitory Activity of Oligonucleotides on TLR7 Sensing
Ferrand, J., & Gantier, M. P. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3335-8_5 · Cited by 12
Toll-Like Receptor Agonists Modulate Wound Regeneration in Airway Epithelial Cells
Lewandowska‐Polak, A., Brauncajs, M., Jarzębska, M., Pawelczyk, M., Kurowski, M. M., Chałubiński, M., Makowska, J. S., & Kowalski, M. L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082456 · Cited by 12
Nuevas dianas terapéuticas en el lupus sistémico (parte 1/2)
Giraldo, W. A. S., Villanueva, M. J. G., Boteanu, A. L., Iglesias, A. L., & Mendoza, A. C. Z. (2012) · Reumatología Clínica · doi:10.1016/j.reuma.2012.01.012 · Cited by 16
Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
Morris, G., Athan, E., Walder, K. R., Bortolasci, C. C., O'Neil, A. E., Marx, W., Berk, M., Carvalho, A. F., Maes, M. H. J., & Puri, B. K. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118541 · Cited by 12
Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19
Veld, A. E. I. ‘., Jansen, M. A. A., Ciere, L. C. A., & Moerland, M. (2021) · Journal of Immunology Research · doi:10.1155/2021/6659410 · Cited by 15
Targeted Therapies in Autoimmune Skin Diseases
Braegelmann, C., Niebel, D., & Wenzel, J. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.08.439 · Cited by 12
Targeting DAMPs with nucleic acid scavengers to treat lupus
Olson, L. B., Hunter, N. I., Rempel, R. E., & Sullenger, B. A. (2022) · Translational research · doi:10.1016/j.trsl.2022.02.007 · Cited by 13
Yuan, Y., Ling, Z. H. A. O., Ning, M. A., Zhuang, Y. E., JIANG, Z., & Congqiu, C. H. U. (2017) · Archives of Rheumatology · doi:10.5606/archrheumatol.2017.6279 · Cited by 11
Pharmaceutical strategies for optimized mRNA expression
Shi, Y., Mao, J., Wang, S., Ma, S., Luo, L., & You, J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122853 · Cited by 11
Hydroxychloroquine alleviates the neurotoxicity induced by anti-ribosomal P antibodies
Zhao, X., & Yang, P. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577648 · Cited by 11
Betschart, C., Faller, M., Zink, F., Hemmig, R., Blank, J., Vangrevelinghe, E., Bourrel, M., Glatthar, R., Behnke, D., Barker, K., et al. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00696 · Cited by 11
New Therapeutic Targets in Systemic Lupus
Giraldo, W. A. S., Villanueva, M. J. G., Boteanu, A. L., Iglesias, A. L., & Mendoza, A. C. Z. (2012) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2012.06.011 · Cited by 13
Dyckhoff-Shen, S., Masouris, I., Islam, H., Hammerschmidt, S., Angele, B., Marathe, V., Buer, J., Völk, S., Pfister, H., Klein, M., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.165737 · Cited by 10
Myeloid cells as IFNα producers in systemic lupus erythematosus
Kuga, T., Chiba, A., Murayama, G., & Miyake, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1562221 · Cited by 10
Ni, J., Li, X., Tu, X., Zhu, H., Wang, S., Hou, Y., & Dou, H. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109487 · Cited by 12
Veld, A. E. I. ‘., Grievink, H. W., van der Plas, J. L., Maarse, B. C. E., van Kraaij, S. J. W., Woutman, T. D., Schoonakker, M., Klarenbeek, N. B., de Kam, M. L., Kamerling, I. M. C., et al. (2023) · Immunologic Research · doi:10.1007/s12026-023-09367-3 · Cited by 10
He, W.-J., Wang, J., Liu, N., Li, G.-Y., Zhu, X., Yao, L., & Liu, L. (2024) · Journal of Nephrology · doi:10.1007/s40620-023-01839-x · Cited by 10
Trujillo, G., Regueiro‐Ren, A., Liu, C., Hu, B., Sun, Y. S., Ahangari, F., Fiorini, V., Ishikawa, G., Jumaily, K. A., Khoury, J., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202401-0065oc · Cited by 13
Sharma, R. K., Sehgal, S., Sachdeva, N. K., Kumar, R., & Gupta, A. (2018) · Immunological Investigations · doi:10.1080/08820139.2018.1515223 · Cited by 10
Kumar, A., Sharma, A., Tirpude, N. V., Thakur, S., & Kumar, S. (2021) · Current Molecular Medicine · doi:10.2174/1566524021666210803154250 · Cited by 11
Zhang, J., Lu, X., Feng, J., Li, H., & Wang, S. (2021) · BioMed Research International · doi:10.1155/2021/9171715 · Cited by 11
Antimicrobial therapies for chronic pain (part 1): analgesic mechanisms
Wang, E. J., Karri, J. V., Tontisirin, N., & Cohen, S. P. (2023) · The Korean journal of pain · doi:10.3344/kjp.23129 · Cited by 10
Optimizing pharmacotherapy of systemic lupus erythematosus: the pharmacist role
Hussaini, M. A., Hammouda, E. I., & Hammouda, A. (2014) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-014-9966-1 · Cited by 11
Bioconjugation of Small Molecules to RNA Impedes Its Recognition by Toll-Like Receptor 7
Hellmuth, I., Freund, I., Schlöder, J., Seidu‐Larry, S., Thüring, K. L., Slama, K., Langhanki, J., Kaloyanova, S. S., Eigenbrod, T., Krumb, M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00312 · Cited by 14
Rasmussen, N., Nielsen, C. T., Nielsen, C. H., & Jacobsen, S. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13569 · Cited by 10
Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19
Malek, R. J., Bill, C. A., & Vines, C. M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112276 · Cited by 10
Chemical reagents modulate nucleic acid-activated toll-like receptors
Li, X., Sun, X., Guo, X., Li, X., Peng, S., & Mu, X. N. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112622 · Cited by 12
Rasouli, M., Vakilian, F., & Ranjbari, J. (2020) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x16666201221151853 · Cited by 9
Metadata
- Authors
- Kužnik, A., Benčina, M., Švajger, U., Jeras, M., Rozman, B., & Jerala, R.
- Affiliations
- National Institute of Chemistry (SI)
- Blood Transfusion Centre of Slovenia (SI)
- Ljubljana University Medical Centre (SI)
- University of Ljubljana (SI)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-04
- Volume
- 186
- Issue
- 8
- Pages
- 4794-4804
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2118400571
- Cited by
- 606
- References
- 40
- Citations by year
- 2026: 21 · 2025: 24 · 2024: 43 · 2023: 30 · 2022: 42 · 2021: 69 · 2020: 89 · 2019: 38 · 2018: 39 · 2017: 38 · 2016: 41 · 2015: 43 · 2014: 32 · 2013: 22 · 2012: 28
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Repository of the University of Ljubljana (University of Ljubljana) (publishedVersion, other-oa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- antimalarial drugs, imidazoquinolines, chloroquine, hydroxychloroquine, quinacrine, TLR8, R848, nucleic acid binding, endosomal acidification, TLR9, TLR3, TLR7/8 agonist, systemic lupus erythematosus, autoimmune disease therapy, propidium iodide, bafilomycin
- MeSH terms
- Animals, Antimalarials, Binding, Competitive, Cell Line, Cells, Cultured, Chloroquine, Culture Media, Humans, Hydrogen-Ion Concentration, Imidazoles, Nucleic Acids, Quinacrine, Quinolines, Endosomes, Transfection, Cytokines, Serum, Toll-Like Receptors, Toll-Like Receptor 3, Toll-Like Receptor 7, Toll-Like Receptor 8, Toll-Like Receptor 9, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.